Parataxis Korea, Inc. (KOSDAQ:288330)
South Korea · Delayed Price · Currency is KRW 416.00
-13.00 (-3.03%)
At close: Apr 7, 2026
Parataxis Korea Market Cap
Parataxis Korea has a market cap or net worth of 44.13 billion as of October 16, 2026. It is the 33,369th most valuable company in the world and the 1,893rd biggest in South Korea. Its market cap has decreased by 88.74% in one year.
Market Cap
44.13B
Enterprise Value
42.20B
Revenue
1.59B
Global Rank
Country Rank
#1,893 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2019, Parataxis Korea's market cap has decreased from 300.15B to 44.13B, a decrease of -85.30%. That is a compound annual growth rate of -26.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 44.13B | -43.78% |
| Dec 30, 2025 | 78.49B | -58.48% |
| Dec 30, 2024 | 189.04B | 158.57% |
| Dec 28, 2023 | 73.11B | -68.32% |
| Dec 29, 2022 | 230.80B | -17.53% |
| Dec 30, 2021 | 279.85B | 0.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ADBiotech | 56.73B |
| KoBioLabs | 54.57B |
| TegoScience | 53.64B |
| NovMetaPharma | 51.37B |
| J2KBIO | 50.87B |
| QuadMedicine | 48.22B |
| Epibiotech | 43.62B |
| HLB Pep | 40.51B |